Annual accounts
Total Exemption Full accounts
31/12/2026Filing deadline
- Next accounts made up to
- 31/03/2026
- Last accounts made up to
- 31/03/2025
Reference data exactly as held at Companies House.
The 4 most recent documents filed at Companies House.
Confirmation statement made on 2026-08-23 with no updates
Total exemption full accounts made up to 2025-03-31
Director's details changed for Mr Robert George Boyle on 2025-10-10
Confirmation statement made on 2025-08-23 with no updates
What Pre-Score will tell you

The two filings Companies House requires every year, and where each one stands against its deadline today.
Total Exemption Full accounts
31/12/2026Filing deadline
Confirms the registry record is up to date
The latest figures SENTINEL ONCOLOGY LIMITED filed. Okredo holds filed accounts data for 2021–2025; the year-by-year record is on the financials page.
Net Assets
2024: £5.41M
Total Assets
2024: £5.83M
Cash in Bank
2024: £5.56M
Total Liabilities
2024: £402.33K
Employees
2024: 5
Of the 4 measures with an earlier filing to compare against, 4 fell. Cash in bank moved furthest, down 15.75% on 2024. See the full financial analysis for SENTINEL ONCOLOGY LIMITED.
The full financial record
Four ways through SENTINEL ONCOLOGY LIMITED's filed accounts — the year-by-year numbers, the compound rates and the ratios behind them.
Headcount as reported to Companies House for 2021–2025.
| Year | Employees | Change |
|---|---|---|
| 2025 | 6 | +1 |
| 2024 | 5 | -1 |
| 2023 | 6 | +1 |
| 2022 | 5 | 0 |
| 2021 | 5 | – |
Reported employee count increased from 5 in 2021 to 6 in 2025. See how headcount moved alongside the reported financials.
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
Directors, secretaries and other appointed officers, with the period each has served.
| Person | Role | Period | Connected companies |
|---|---|---|---|
| Director | 01/02/2010–Present | 3 | |
| Director | 27/03/2006–Present | 2 | |
| Director | 14/03/2011–Present | 12 | |
| Nominee Secretary | 19/01/2005–19/01/2005 | 2033 | |
| Nominee Director | 19/01/2005–19/01/2005 | 2133 | |
| Director | 01/02/2010–14/03/2011 | 8 | |
| Director | 19/01/2007–01/02/2008 | 13 | |
| Director | 17/05/2005–Present | 5 | |
| Director | 27/03/2006–29/05/2014 | 5 | |
| Director | 30/06/2005–Present | 3 | |
| Secretary | 19/01/2005–20/05/2006 | 5 | |
| Secretary | 20/05/2006–Present | 0 | |
| Director | 19/01/2005–Present | 0 |
Individuals or entities with significant control over the company, as declared to Companies House.
| Person | Period | Connected companies |
|---|---|---|
| 19/01/2017–Present | 0 | |
| 29/01/2025–Present | 3 | |
| 29/01/2025–Present | 0 |
Every document on the Companies House record, newest first.
Confirmation statement made on 2026-08-23 with no updates
Total exemption full accounts made up to 2025-03-31
Director's details changed for Mr Robert George Boyle on 2025-10-10
Confirmation statement made on 2025-08-23 with no updates
Withdrawal of a person with significant control statement on 2025-01-29
Notification of Robert George Boyle as a person with significant control on 2025-01-29
Notification of Stuart Travers as a person with significant control on 2025-01-29
Total exemption full accounts made up to 2024-03-31
Confirmation statement made on 2024-08-23 with updates
Director's details changed for Mr Gavin Alexander Simpson on 2017-12-01
Confirmation statement made on 2024-01-19 with updates
Total exemption full accounts made up to 2023-03-31
Showing 12 of 15 filings
See when the next accounts and confirmation statement are due
84 UK companies are similar to SENTINEL ONCOLOGY LIMITED, sharing the same company status (Active), the same industry sector and activity group (Research and experimental development on biotechnology) and a comparable number of employees. The 5 closest matches are shown below to help you compare competitors and industry peers.
2 Communications Road, Greenham Business Park, Newbury, Berkshire RG19 6AB
Allia Future Business Centre, Kings Hedges Road, Cambridge CB4 2HY
The Lexicon Second Floor, Mount Street, Manchester M2 5NT
Spitfire House 19 Falcon Court, Preston Farm Industrial Estate, Stockton-On-Tees TS18 3TU
76 Portland Place, London W1B 1NT
A short description of the company, written from its Companies House record.
SENTINEL ONCOLOGY LIMITED is a private limited company registered in the United Kingdom, based in 181 Science Park Milton Road, Cambridge, Cambridgeshire CB4 0GJ. Companies House classifies its business as Research and experimental development on biotechnology. It has been on the register for 21 years 8 months.
The register currently records it as active. Its 2025 accounts report net assets of £4.72M and 6 employees.
Answered from this company's own registry record and filed figures.
Companies House records SENTINEL ONCOLOGY LIMITED under one registered business activity: Research and experimental development on biotechnology (72.11 - SIC 2007).
SENTINEL ONCOLOGY LIMITED is recorded as active on the Companies House register, and has been on it since 19/01/2005.
The most recent accounts Okredo holds cover 2025 and report net assets of £4.72M, total assets of £4.96M, cash in bank of £4.68M and total liabilities of £220.71K.
The most recent document on the record is dated 08/09/2026: Confirmation statement made on 2026-08-23 with no updates, less than a month ago.
On the current registry record, accounts are due by 31/12/2026.
Companies House lists 13 officers (7 currently in post) and 3 people with significant control.